The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges in critical care medicine, including extreme demand for intensive care unit (ICU) resources …
L Tan, MM Zhong, Q Liu, Y Chen, YQ Zhao… - Frontiers in Cellular …, 2023 - frontiersin.org
Objectives: The purpose of this study was to evaluate available evidence on the association between the human oral microbiota and coronavirus disease 2019 (COVID-19) and …
V Trimarco, R Izzo, A Lombardi, A Coppola… - Pharmacological …, 2023 - Elsevier
We have recently demonstrated in a double-blind randomized trial the beneficial effects of L- Arginine in patients hospitalized for COVID-19. We hypothesize that one of the mechanisms …
Z Malekinejad, A Baghbanzadeh, A Nakhlband… - Life Sciences, 2022 - Elsevier
The highly pathogenic, novel coronavirus disease (COVID-19) outbreak has emerged as a once-in-a-century pandemic with poor consequences, urgently calling for new therapeutics …
M Qi, W Sun, K Wang, W Li, J Lin, J Gong… - International Journal of …, 2023 - mdpi.com
Both periodontitis and Coronavirus disease 2019 (COVID-19) pose grave threats to public health and social order, endanger human life, and place a significant financial strain on the …
X Zhou, W Sun, Y Zhang, H Gu, R Wang, P Xie… - Frontiers in …, 2023 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission is responsible for the coronavirus disease 2019 (COVID-19) pandemic. SARS-CoV-2 uses the …
Coronavirus disease 2019 (COVID-19) is caused by a severe acute respiratory syndrome, coronavirus type 2 (SARS-CoV-2), leading to acute tissue injury and an overstated immune …
Background Inflammation is at the core of many chronic conditions and exacerbates infectious conditions, including the severity of coronavirus disease 2019 (COVID-19) …
During the current pandemic, the vast majority of COVID-19 patients experienced mild symptoms, but some had a potentially fatal aberrant hyperinflammatory immune reaction …